L, Michelle Angeli, et al. “THE INCIDENCE OF DYSLIPIDEMIA AND DIABETES MELLITUS TYPE 2 AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS USING THE FIRST LINE HIGHLY ACTIVE ANTIRETRO-VIRAL THERAPY FOR AT LEAST TWELVE MONTHS IN SOUTHERN PHILIPPINES HIV-AIDS CORE TEAM HUB”. Journal of the ASEAN Federation of Endocrine Societies, vol. 34, July 2019, p. 17, https://asean-endocrinejournal.org/index.php/JAFES/article/view/4149.